ASHP Pharmacy Practice

Pharmacist-Initiated Therapy Microcredentials Can Boost Your Practice

Published: October 23, 2023
Product Showcase

Attending the Midyear? Visit the ASHP Experience Center (in the Exhibit Hall) or the ASHP Store & Product Showcase (convention center main lobby, level 1), to explore our growing catalog of microcredentials for today’s pharmacy practitioners.

Not familiar with microcredentials? They’re short, stackable activities for learners trying to develop specific pharmacy skills.

ASHP’s microcredentials are intensely focused on skill development to help pharmacists advance their professional goals, build their resumes, and demonstrate competency. Microcredentials provide education and training on an array of pharmacist-initiated services for specific health conditions and signal an advanced level of competency to employers.

Depending on your personal career path and where you live, ASHP’s pharmacist-initiated therapy microcredentials align with state specific point-of-care testing and diagnostic services, including ambulatory respiratory infections, HIV pre- and postexposure prophylaxis, and continuous glucose monitoring. Microcredentials prepare pharmacists to expand their patient care services, and patients benefit when pharmacists are directly involved in their medication-related care.

ADVERTISEMENT

Posted October 23, 2023
ADVERTISEMENT

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information